Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer

Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer

10.1177/17407745211009547

Saved in:
Bibliographic Details
Main Authors: Schaffer, Elisabeth M, Basch, Ethan M, Schwab, Gisela M, Bennett, Antonia V
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Article
Published: SAGE Publications 2023
Subjects:
Mental recall
randomized phase 3 drug trial
cancer pain
patient-reported outcome
Online Access:https://scholarbank.nus.edu.sg/handle/10635/239598
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1177/17407745211009547

Similar Items